Initiation of immunotherapy with activated natural killer cells and anti-GD2 antibody dinutuximab prior to resection of primary neuroblastoma prolongs survival in mice
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Initiation of immunotherapy with activated natural killer cells and anti-GD2 antibody dinutuximab prior to resection of primary neuroblastoma prolongs survival in mice
Authors
Keywords
-
Journal
Journal for ImmunoTherapy of Cancer
Volume 8, Issue 2, Pages e001560
Publisher
BMJ
Online
2020-12-24
DOI
10.1136/jitc-2020-001560
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neoadjuvant checkpoint blockade for cancer immunotherapy
- (2020) Suzanne L. Topalian et al. SCIENCE
- Anti-CD105 Antibody Eliminates Tumor Microenvironment Cells and Enhances Anti-GD2 Antibody Immunotherapy of Neuroblastoma with Activated Natural Killer Cells
- (2019) Hong-Wei Wu et al. CLINICAL CANCER RESEARCH
- A Phase II Trial of Hu14.18K322A in Combination with Induction Chemotherapy in Children with Newly Diagnosed High-Risk Neuroblastoma
- (2019) Wayne L. Furman et al. CLINICAL CANCER RESEARCH
- A rationale for surgical debulking to improve anti-PD1 therapy outcome in non small cell lung cancer
- (2019) Florian Guisier et al. Scientific Reports
- Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
- (2018) Patrick M. Forde et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neoadjuvant Interferons: Critical for Effective PD-1–Based Immunotherapy in TNBC
- (2017) Natasha K. Brockwell et al. Cancer Immunology Research
- TGFβR1 Blockade with Galunisertib (LY2157299) Enhances Anti-Neuroblastoma Activity of the Anti-GD2 Antibody Dinutuximab (ch14.18) with Natural Killer Cells
- (2016) Hung C. Tran et al. CLINICAL CANCER RESEARCH
- A novel minimal residual disease model of neuroblastoma in mice
- (2016) Jeremy R. Jackson et al. JOURNAL OF PEDIATRIC SURGERY
- Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic Disease
- (2016) J. Liu et al. Cancer Discovery
- Growth and Activation of Natural Killer Cells Ex Vivo from Children with Neuroblastoma for Adoptive Cell Therapy
- (2013) Y. Liu et al. CLINICAL CANCER RESEARCH
- Membrane-bound TRAIL Supplements Natural Killer Cell Cytotoxicity Against Neuroblastoma Cells
- (2013) Michael A. Sheard et al. JOURNAL OF IMMUNOTHERAPY
- Clinical Significance of Tumor-Associated Inflammatory Cells in Metastatic Neuroblastoma
- (2012) Shahab Asgharzadeh et al. JOURNAL OF CLINICAL ONCOLOGY
- Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells
- (2012) Cecele J. Denman et al. PLoS One
- Activating Signals Dominate Inhibitory Signals in CD137L/IL-15 Activated Natural Killer Cells
- (2011) Hua Zhang et al. JOURNAL OF IMMUNOTHERAPY
- Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
- (2010) Alice L. Yu et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now